Thrilled to finally share some significant Octant milestones today, including our $80 million Series B funding led by @CatalioCapital https://t.co/8I1NS3FAJp
Excited to connect with biotech adventurers at the Stanford Drug Discovery Symposium! @rplenge and @diane_dickel will share the results of our @bmsnews collaboration on deep mutational scans of TYK2, an important target for the treatment of autoimmune phenotypes. #SDDS2024
We're thrilled to welcome back @johnnyleebio, an original Octant Apprentice. Completing his medical degree at USC, he's now teaming up with us to push our rare disease programs to clinical development. For more details on our programs, see here! octant.bio/pipeline